5 UK Companies Working Across Women’s and Maternal Health
The UK women’s and maternal health sector includes companies working across reproductive testing, gynaecological diagnostics, hormone prescribing, fertility support and maternal-infant biology. The companies in this guide are not all solving the same problem, but each sits in an area where testing, sampling, prescribing or care pathways remain technically and clinically difficult.
Some are developing new approaches to sample collection. Others are building digital platforms around hormone testing, treatment matching or reproductive health data. Together, they show how the category extends beyond a single “femtech” label and into diagnostics, software, clinical services and microbiome science.
This is a selected Benchscope guide, not an exhaustive ranking. Companies are included based on their stated services, location, relevance to the topic and presence within the Benchscope life sciences dataset.
Hertility Health
Hertility Health provides at-home hormone and fertility testing through a digital health platform. Founded in 2019 and based in London, the company combines blood collection kits, laboratory testing, doctor-written reports and onward care pathways for users seeking reproductive health support.
Its platform is relevant to people looking for a more accessible route into hormone assessment, fertility information and specialist follow-up. Hertility’s services also connect users with options such as gynaecology consultations, fertility counselling, ultrasound scans and egg-freezing support. In this guide, Hertility sits between women’s health diagnostics, digital health and consumer-facing reproductive health services.
View Hertility Health on Benchscope →
Ellele Health
Ellele Health is a Cambridge-based company developing vaginal sampling technology for gynaecological diagnostics. Rather than relying only on conventional sample types, the company’s approach is built around collecting material from the vaginal environment, which can then support analysis using genetic, epigenomic and microbial methods.
The company is based at Granta Park and is part of The Origin Group Limited. Its work builds on proprietary mucosal sampling technology and applies that approach to gynaecological diagnostics, including ovarian and endometrial cancer biomarker discovery. Ellele fits this guide because it focuses on a practical problem in women’s health diagnostics: how to collect useful biological material in a way that is less invasive and suited to conditions affecting reproductive tissues.
View Ellele Health on Benchscope →
Woost
Woost is a London women’s health research company with Imperial College London listed among its collaborators. Its work focuses on menstrual blood as a source of biological information, with the aim of developing tools that can support research and future testing for gynaecological and reproductive health conditions.
The company’s current work is especially relevant to PCOS, a common condition where diagnosis and care pathways can be slow or fragmented. Woost adds a different sampling route to this guide because it is exploring menstrual blood rather than conventional blood draws or clinic-based sampling. Its model is still early-stage, but it reflects a wider interest in using underused biological samples to improve women’s health research.
View Woost on Benchscope →
Dama Health
Dama Health is a London health technology company working on clinical decision support for hormone therapy and contraceptive prescribing. Founded in 2021, the company collects patient information and uses digital tools to help clinicians make more personalised hormone-care decisions.
Its relevance to this guide comes from the prescribing side of women’s health. Hormone therapy and contraceptive selection can involve trial and adjustment, particularly where side effects, medical history and patient preferences need to be balanced. Dama’s platform is designed to add a more structured layer to that process, including work around pharmacogenomics and personalised hormone health.
View Dama Health on Benchscope →
BoobyBiome
BoobyBiome sits at the maternal-infant edge of this guide. It is not a women’s health company in the narrow clinical sense, but breast milk biology is central to its work.
Founded in 2019 and based in London, the company has links to UCL and the Great Ormond Street Institute of Child Health. BoobyBiome works on the breast milk microbiome and is developing products intended to support infant gut health, including a supplement based on microbes isolated from human milk.
Its work fits this article because maternal biology provides the scientific foundation. The market case is infant health, but the technical focus sits close to lactation, breast milk storage and the transfer of beneficial microbes from mother to infant.
View BoobyBiome on Benchscope →
Wider view
These companies show that UK women’s and maternal health activity is not concentrated in one type of business. Hertility and Dama are building digital layers around testing, prescribing and care navigation. Ellele and Woost are focused on sample collection and diagnostics, using vaginal and menstrual samples rather than relying only on conventional blood-based pathways. BoobyBiome extends the theme into maternal-infant microbiome science, where breast milk biology becomes the basis for infant health products.
That spread matters because women’s health is not a single market. It includes diagnostics, fertility, hormone therapy, gynaecological disease, maternal health and long-term care pathways. For Benchscope, the category works best when it is treated as a connected set of technical problems rather than a broad label.
Browse other women’s and maternal health organisations listed on Benchscope, or explore more life science companies by location, category and focus area. If your company is listed and would like to update your profile, or if you think we have missed a relevant organisation, submit an update through Benchscope.